Work Here?
Motif Neurotech
Work Here?
Designs wireless-powered neural implants for medicine
Motif Neurotech
Work Here?
Designs wireless-powered neural implants for medicine
Overview
Motif Neurotech develops neural implants that are powered wirelessly by magnetic fields from an external wearable transmitter, enabling minimally invasive operation for medical and research use. The devices are designed for both animal studies and human applications, with a full-stack engineering approach that covers PCB design, embedded firmware, and system integration. Revenue comes from selling the neural implants and through partnerships with medical institutions and research organizations. The company emphasizes regulatory compliance and quality management, using an electronic quality management system (eQMS) to move research devices toward market-ready products. Its main goal is to scale its operations and team to advance neurotechnology by delivering reliable, compliant, and field-ready neural implant solutions.
About Motif Neurotech
Industries
Robotics & Automation
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$18.9M
Headquarters
Houston, Texas
Founded
2022
Simplify's Take
What believers are saying
- FDA cleared RESONATE’s first feasibility trial on April 27, 2026.
- Eight-site enrollment improves recruitment, credibility, and future reimbursement evidence.
- ARPA-H EVIDENT and MintNeuro partnership add data, supply, and validation support.
What critics are saying
- One safety event in RESONATE can derail financing and regulatory momentum.
- Abbott, Neuralink, and TMS vendors pressure adoption before Motif proves efficacy.
- Wireless power, chip integration, and supply-chain failures can delay pivotal studies.
What makes Motif Neurotech unique
- DOT is a blueberry-sized, battery-free implant placed above the dura.
- Rice University origin gives Motif exclusive wireless power technology and clinical depth.
- MintNeuro chips enable programmable sensing, stimulation, and future closed-loop therapy.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$18.9M
Above
Industry Average
Funded Over
2 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 3%2 year growth
↑ 6%Motif Neurotech is developing a neurostimulator system that works like a pacemaker for the brain and is now used for treating severe depression.
Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK’s Advanced Research and Invention Agency (ARIA) for mu
After announcing last September that it had logged the first successful implantation of its pea-sized neurostimulator for depression, Motif Neurotech has raised $18.75 million in venture capital fu | After announcing last September that it had logged the first successful implantation of its pea-sized neurostimulator for depression, Motif Neurotech has raised $18.75 million in VC funds.
HOUSTON - (Jan. 24, 2023) - Rice University today announced that Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, closed an oversubscribed Series A financing round of $18.75 million.
As part of the round, Tom Shehab, managing partner of Arboretum, and Amy Kruse, chief investment officer at Satori Neuro, will join Motif's board.
Motif Neurotech is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Motif Neurotech
Industries
Robotics & Automation
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$18.9M
Headquarters
Houston, Texas
Founded
2022
Motif Neurotech is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today